Literature DB >> 2802536

Experimental autoimmune motoneuron disease.

J I Engelhardt1, S H Appel, J M Killian.   

Abstract

An animal model of disease of the lower motoneurons has been developed by inoculating guinea pigs with bovine motoneurons. Four of 9 immunized female animals and 4 of 5 immunized male animals developed symptoms of neuromuscular degeneration marked by weakness, evidence of denervation by electromyographic and morphological criteria, and a loss of motoneurons within the spinal cord. No inflammatory foci were noted within parenchyma or meninges of the central nervous system. The immunized guinea pigs developed high serum titers of IgG class antibodies to motoneurons. Immunohistochemical studies demonstrated the presence of IgG within spinal cord motoneurons and at the end-plates of immunized animals. This experimental autoimmune motoneuron disease may provide important insights into the cause and pathogenesis of amyotrophic lateral sclerosis, a human motoneuron disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802536     DOI: 10.1002/ana.410260310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Development of amyotrophic lateral sclerosis in the course of systemic lupus erythematosus.

Authors:  X Forns; X Bosch; F Graus; M Navarro; J Font
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

2.  Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins.

Authors:  O Delbono; J García; S H Appel; E Stefani
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

3.  Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls.

Authors:  Koyi Choi; Hean Zhuang; Barbara Crain; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2008-03-18       Impact factor: 3.478

4.  The action of amyotrophic lateral sclerosis immunoglobulins on mammalian single skeletal muscle Ca2+ channels.

Authors:  V Magnelli; T Sawada; O Delbono; R G Smith; S H Appel; E Stefani
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

5.  Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis.

Authors:  Y Tsuboi; T Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

6.  Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction.

Authors:  S H Appel; J I Engelhardt; J García; E Stefani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

7.  Specific electron transport chain abnormalities in amyotrophic lateral sclerosis.

Authors:  Jerry Lin; Andrew Diamanduros; Soheli A Chowdhury; Stephen Scelsa; Norman Latov; Saud A Sadiq
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

8.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

Review 9.  Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy.

Authors:  Peter de Haan; Hans C Klein; Bert A 't Hart
Journal:  Front Psychiatry       Date:  2017-04-04       Impact factor: 4.157

Review 10.  Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

Authors:  Tiziana Bonifacino; Roberta Arianna Zerbo; Matilde Balbi; Carola Torazza; Giulia Frumento; Ernesto Fedele; Giambattista Bonanno; Marco Milanese
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.